CytomX Therapeutics, Inc.【CTMX】 業績推移・財務諸表

(単位:千ドル) 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25
売上高 1,939 1,988 2,223 3,094 3,454 6,272 11,653 8,752 24,144 27,074 14,184 21,338 12,509 11,471 29,485 9,013 10,712 8,279 49,593 16,608 17,788 15,971 16,288 17,587 17,136 18,165 16,915 23,499 24,724 26,384 41,463 25,115 33,432 50,917
売上成長率(%) - - - -
研究開発費 9,157 - 13,365 12,705 13,337 - 14,576 28,076 28,920 - 22,458 25,553 27,549 - 36,376 30,835 27,967 - 42,814 24,066 24,049 22,371 26,100 29,143 30,559 31,159 30,367 21,175 20,671 16,448 22,052 25,172 21,368 18,868
営業費用 13,208 - 18,405 17,352 18,370 - 20,267 34,125 35,169 - 29,814 34,595 35,686 - 46,050 40,246 36,430 - 52,386 32,746 32,683 31,598 35,493 40,228 41,102 42,907 40,857 29,152 28,072 23,261 29,806 33,567 29,321 28,296
営業利益 -11,269 - -16,182 -14,258 -14,916 - -8,614 -25,373 -11,025 - -15,630 -13,257 -23,177 -25,811 -16,565 -31,233 -25,718 - -2,793 -16,138 -14,895 -15,627 -19,205 -22,641 -23,966 -24,742 -23,942 -5,653 -3,348 3,123 11,657 -8,452 4,111 22,621
営業利益率 (%) - - - -
経常(税引前)利益 -11,867 - -16,026 -14,173 -14,661 - -8,258 -25,190 -10,266 - -14,395 -11,656 -20,929 -23,321 -14,130 -28,960 -23,699 - -1,706 -15,679 -14,710 -15,554 -19,243 -22,584 - - - - - 5,815 13,840 -6,483 5,797 23,587
経常(税引前)利益率(%) -612.02 - -720.92 -458.08 -424.46 - -70.87 -287.82 -42.52 - -101.49 -54.63 -167.31 -203.3 -47.92 -321.31 -221.24 - -3.44 -94.41 -82.7 -97.39 -118.14 -128.41 - - - - - 22.04 33.38 -25.81 17.34 46.32
法人税等合計 3 - 3 3 1 - -1 26 -19 - 1,098 1,791 2,502 8,912 -6 0 0 - -13,900 - - - - - - - - - - 2,823 49 51 61 62
実効税率(%) - - - - - - - - - - - - - -
純利益 -11,870 -11,487 -16,029 -14,176 -14,662 -14,033 -8,257 -25,216 -10,247 621 -15,493 -13,447 -23,431 -32,233 -14,124 -28,960 -23,699 -35,455 12,205 -15,679 -14,710 -15,554 -19,243 -22,584 -23,885 -24,184 -23,296 -3,311 -1,087 2,992 13,791 -6,534 5,736 23,525
純利益率(%)